Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in NEO — Neogenomics Inc

CIK 1166588 NEW YORK, NY

Position in NEO

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$815,376
-$513,127 QoQ
Shares Held
109,889
-2.7% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Derivatives in NEO

reported options exposure · as of Sep 30, 2021
CallValue
$0
CallShares
0
PutValue
$21,708
PutShares
450

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

BNP PARIBAS ARBITRAGE, SA holds $1,382,552,556 across 39 Diagnostics & Research names. NEO ranks #25 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NEO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $815,376 109,889
2025-12-31 $1,328,503 112,968
2025-09-30 $3,650,988 472,926
2025-06-30 $1,762,901 241,163
2025-03-31 $320,287 33,750
2024-12-31 $609,496 36,984
2024-09-30 $1,076,204 72,963
2024-06-30 $481,635 34,725
2024-03-31 $1,348,068 85,755
2023-12-31 $1,640,020 101,361
2023-09-30 $2,642,076 214,803
2023-06-30 $2,925,800 182,066
2023-03-31 $2,964,522 170,277
2022-12-31 $561,431 60,761
2022-06-30 $327,189 40,146
2022-03-31 $399,467 32,878
2021-12-31 $1,897,925 55,625
2021-09-30 $21,708 450
2021-09-30 $5,765,114 119,509
2021-06-30 $2,056,635 45,531
2021-03-31 $1,246,166 25,838
2020-12-31 $1,188,248 22,070
2020-09-30 $982,417 26,631
2020-06-30 $275,350 8,888
2020-03-31 $1,134,577 41,093